Timothy J.Melton (Tim)

Partner-in-Charge Detroit

Detroit + 1.313.230.7969 Chicago + 1.312.269.4154

Tim Melton, a corporate lawyer with more than 30 years of deal experience, has served as lead counsel on hundreds of transactions with total transaction values well in excess of $100 billion. Tim is a go-to counselor and adviser for a wide variety of clients, many of which he has served for decades. He regularly advises public and private companies and their boards of directors on matters relating to corporate governance, M&A, debt and equity tender offers, distressed debt, securities regulations, financing strategies and alternatives, and stockholder activism. Tim also has experience representing special committees in going private transactions as well as internal investigations. He represents financial institutions as well in connection with public and private financings and various restructuring scenarios.

Tim recently represented Cardinal Health in connection with its $6.1 billion acquisition of a patient product portfolio, Reynolds American in its $49 billion acquisition by British American Tobacco, Procter & Gamble in the $12.5 billion sale of its beauty brands, USG in its sale of $500 million of Senior Notes, and Goldman Sachs in its underwritten public offering of notes issued by First Midwest Bancorp.

Tim is Partner-in-Charge of Jones Day's Detroit Office and previously served as co-head of the Firm's Capital Markets Practice. He is a member of the Executive Committee and currently serves as chair of the Ray Garrett Jr. Corporate Securities Law Institute and serves as a member (past chair) of the Advisory Board of Cabrini Green Legal Aid.

Experience

  • MYR Group acquires CSI Electrical Contractors, Inc.Jones Day advised MYR Group Inc. in its acquisition of substantially all the assets of CSI Electrical Contractors, Inc., a full-service electrical contractor headquartered in Santa Fe Springs, California.
  • USG acquired by Gebr. Knauf for $7 billionJones Day advised USG Corporation in the acquisition by Gebr. Knauf KG ("Knauf") of all of the outstanding shares of USG in a transaction valued at $7 billion.
  • Grupo Kuo obtains US$300 million multi-draw revolving loanJones Day represented Grupo Kuo, S.A.B. de C.V., a Mexico-based industrial and commercial global holding company, and its subsidiaries in connection with a US$300 million multi-draw revolving loan financing comprised of a U.S. dollar tranche and a Mexican Peso tranche provided by a syndicate of major financial institutions.
  • Grupo Kuo obtains US$175 million senior unsecured term loanJones Day represented Grupo Kuo, S.A.B. de C.V., a Mexico-based industrial and commercial global holding company, in connection with a US$175 million senior unsecured term loan provided by Bank of America, N.A.
  • KKR completes investment in OneStream SoftwareJones Day advised Kohlberg, Kravis & Roberts & Co. L.P. in connection with its investment in OneStream Software LLC, a leading provider of cloud or on-premise Corporate Performance Management solutions for mid-sized to large enterprises, in a transaction that values the privately held company at more than $1 billion.
  • USG overcomes plaintiffs' attempt to enjoin merger voteJones Day successfully defended USG Corporation and its board from a preliminary injunction brought to enjoin the stockholders' vote on a proposed merger.
  • Cardinal Health sells majority stake in NaviHealth to Clayton, Dubilier & RiceJones Day advised Cardinal Health, Inc. (NYSE: CAH) in the sale of a majority stake in its NaviHealth business to funds managed by Clayton, Dubilier & Rice.
  • Cooper Standard acquires Lauren Manufacturing and Lauren PlasticsJones Day advised Cooper Standard regarding its acquisition of Lauren Manufacturing and Lauren Plastics, extruders and molders of organic, silicone, thermoplastic and engineered polymer products with expertise in sealing solutions for industrial and specialty automotive applications.
  • Cardinal Health sells its Cardinal Health China distribution business to Shanghai Pharmaceuticals for $1.2 billionJones Day advised Cardinal Health in the $1.2 billion sale of its Cardinal Health China distribution business to Shanghai Pharmaceuticals Holding Co., Ltd.
  • Cardinal Health acquires leading patient product portfolio from Medtronic for $6.1 billionJones Day advised Cardinal Health on the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash.
  • Reynolds American acquired by British American Tobacco Plc in deal valued at $49 billionJones Day advised Reynolds American Inc. ("RAI") regarding the acquisition by British American Tobacco, p.l.c. ("BAT") of 57.8 percent of the outstanding shares of RAI not owned by BAT and its affiliates in a transaction valued at $49 billion.
  • USG issues $500 million of Senior Notes in Rule 144A and Regulation S offering as part of refinancing transactionsJones Day represented USG Corporation, a manufacturer and distributor of building materials, in connection with its issuance of $500 million of 4.875% Senior Notes due 2027 in a Rule 144A and Regulation S offering and concurrent cash tender offer for the company's 7.75% Senior Notes due 2018.
  • Cardinal Health acquires rights to Lymphoseek® from Navidea BiopharmaceuticalsJones Day advised Cardinal Health in its acquisition of Navidea Biopharmaceuticals' rights to Lymphoseek® in North America for lymphatic mapping, lymph node biopsy, and the diagnosis of metastatic spread to lymph nodes for the staging of cancer.
  • Hill-Rom acquires Mortara Instrument for $330 millionJones Day advised Hill-Rom Holdings, Inc. in its acquisition of Mortara Instrument, Inc., a privately held leader in diagnostic cardiology and patient monitoring solutions, technologies, and devices, for $330 million in cash.
  • USG sells L&W Supply Corporation to ABC Supply Co. for $670 millionJones Day advised USG Corporation in connection with its sale of L&W Supply Corporation, and certain other assets related to L&W's distribution business, to ABC Supply Co. Inc. for $670 million in cash.
  • Procter & Gamble sells its beauty brands to Coty for $12.5 billionThe Procter & Gamble Company ("P&G") has merged its 43 beauty brands ("RMT Brands") of global salon professional hair care and color, retail hair color, cosmetics, and fine fragrance businesses, along with select hair styling brands with Coty Inc. in a Reverse Morris Trust transaction for $12.5 billion.
  • Goldman Sachs and Sandler O'Neill lead $150 million underwritten public offering of notes for First Midwest Bancorp, Inc.Jones Day represented Goldman Sachs & Co.; Sandler O’Neill & Partners, L.P.; and Stephens Inc., as underwriters, in connection with First Midwest Bancorp, Inc.’s, a bank holding company with a principal operating subsidiary, First Midwest Bank, $150 million public offering of 5.875% Subordinated Notes due 2026.
  • Procter & Gamble sells Duracell to Berkshire Hathaway for $2.9 billionJones Day advised The Procter & Gamble Company ("P&G") in the sale of its Duracell personal power business to Berkshire Hathaway Inc. for $2.9 billion.
  • Reynolds American sells Natural American Spirit International businesses to JT Group for $5 billionJones Day advised Reynolds American Inc. in its $5 billion sale of the international rights to the Natural American Spirit brand name and associated trademarks, along with the international companies that distribute and market the brand outside the U.S., to the Japan Tobacco Group of companies (JT Group).
  • Cardinal Health acquires Cordis for $1.9 billionJones Day advised Cardinal Health, Inc. in its acquisition of Johnson & Johnson's Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $1.9 billion in cash.
  • Speaking Engagements

    • April 2018
      A Conversation with SEC Division of Corporation Finance Director, Ray Garrett, Jr. Corporate and Securities Law Institute, Northwestern Pritzker School of Law
    • May 2005-2018
      Executive Planning Committee, Ray Garrett, Jr. Corporate and Securities Law Institute
    • April 27, 2016
      International Tax Seminar for Detroit Chapter of Tax Executives Institute
    • June 17, 2014
      Proxy Statement Interactive Seminar
    • June 12, 2014
      Corporate Governance and Public Disclosure Challenges
    • June 9, 2013
      Managing Crisis: The intersection of Internal Investigations, Corporate Governance, and Data Privacy
    • June 7, 2012
      Creative Deal Planning: Thoughts on Current Structures and Exit Strategies, Jones Day Chicago 2012 MCLE University
    • May 2008
      Ethics and Malpractice in Corporate Transactions, Chair, Ray Garrett Jr., Corporate and Securities Law Institute
    • September 2007
      Chairman, SEC Hot Topics Seminar, Glasser Legal Works
    • December 2005
      Corporate Governance Reform, Developments in Securities Laws, Practising Law Institute
    • October 2005
      SEC Hot Topics Seminar, Glasser Legal Works
    • October 2004
      SEC Issues Update Seminar
    • April 2004
      Value Creation Strategies, Houlihan Lokey
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.